Insights

Pharmaceuticals and Life Sciences

Home Expertise Pharmaceuticals and Life Sciences

Filters (0)

Type (0)

Results

All Insights

Report Dec 5, 2024

The devil is in the details: legislative changes and access to healthcare

Legislative amendments are initiating significant developments in health reform.

Read more
The devil is in the details: legislative changes and access to healthcare
Osler Update Sep 16, 2024

Curb your (lobbying) enthusiasm? Navigating Canada’s lobbying regulations – insights for the pharmaceutical industry

The interplay of legal frameworks, ethical considerations and diverse stakeholders make lobbying a complex and sensitive process.

Read more
Curb your (lobbying) enthusiasm? Navigating Canada’s lobbying regulations – insights for the pharmaceutical industry
Osler Update Oct 17, 2023

It ended before it began: first private party sought leave to bring an ‘abuse of dominance’ application under the Competition Act

Just two weeks after applying for leave to the Competition Tribunal seeking a remedial order under the Competition Act “abuse of dominance”...

Read more
Osler Update Feb 23, 2023

Implications of new proposed legislation on the credentialing and employment of healthcare workers in Ontario

Healthcare organizations are well-advised to pay attention to the implications of Bill 60 on the credentialing and hiring (as applicable) of...

Read more
Osler Update Feb 23, 2023

Ontario proposes new legislation for private health facilities and surgical centres

On February 21, 2023, the Ontario government tabled Bill 60, Your Health Act, 2023 (Bill 60), following its recent announcement of its plan to reduce...

Read more
Ontario proposes new legislation for private health facilities and surgical centres
Osler Update Nov 10, 2022

PMPRB releases long-awaited draft guidelines regarding excessive drug pricing under new regime

The Patented Medicine Prices Review Board (PMPRB) has updated its approach to excessive pricing. Osler’s Nathaniel Lipkus and Yael Mansour discuss...

Read more
PMPRB releases long-awaited draft guidelines regarding excessive drug pricing under new regime
Osler Update Mar 2, 2022

From formation to exit: Osler’s Michael Grantmyre works with Alberta tech companies at all stages

Michael Grantmyre joins Osler’s Calgary office in the Emerging and High Growth Companies practice. Find out more.

Read more
Osler Update Feb 7, 2022

How well does Canadian law protect information products? The case of patents over diagnostic methods

While patent law exists to protect the technical contributions of inventors, a recent Australian case illustrates the difficulties of enforcing...

Read more
Osler Update Sep 24, 2021

The impact of CAR T cell patenting on access to therapy in Canada

A recent U.S. court decision provided narrow patent scope for a basic CAR T therapy patent.

Read more
Osler Update Jun 21, 2021

Canadian Animal Health Market Update: Companion animals are getting a lot of attention during COVID-19

Work from home has led to an explosion in pet adoption during the pandemic. This is good news for those involved in Canadian animal health.

Read more

Osler is a leading business law firm practising internationally from offices across Canada and in New York. Our clients include industry and business leaders in all segments of the market and at various stages in the growth of their businesses. We have built our reputation on our commitment to our clients' success and the experience, expertise and collaborative approach for which we are recognized. We believe that our success is a reflection of our clients' success.